The DOI matches its Crossref record.
Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study
Open accessAbstract
Purpose: We questioned the impact of pregnancy on disease-free survival (DFS) in women with history of breast cancer (BC) according to estrogen receptor (ER) status. Patients and Methods: A multicenter, retrospective cohort study in which patients who became pregnant any time after BC were matched (1:3) to patients with BC with similar ER, nodal status, adjuvant therapy, age, and year of diagnosis. To adjust for guaranteed time bias, each nonpregnant patient had to have a disease-free interval at least equal to the time elapsing between BC diagnosis and date of conception of the matched pregnant one. The primary objective was DFS in patients with ER-positive BC. DFS in the ER-negative cohort, whole population, and overall survival (OS) were secondary objectives. Subgroup analyses included DFS according to pregnancy outcome and BC–pregnancy interval. With a two-sided α = 5% and β = 20%, 645 ER-positive patients were required to detect a hazard ratio (HR) = 0.65. Results: A total of 333 pregnant patients and 874 matched nonpregnant patients were analyzed, of whom 686 patients had an ER-positive disease. No difference in DFS was observed between pregnant and nonpregnant patients in the ER-positive (HR = 0.91; 95% CI, 0.67 to 1.24, P = .55) or the ER-negative (HR = 0.75; 95% CI, 0.51 to 1.08, P = .12) cohorts. However, the pregnant group had better OS (HR = 0.72; 95% CI, 0.54 to 0.97, P = .03), with no interaction according to ER status (P = .11). Pregnancy outcome and BC–pregnancy interval did not seem to impact the risk of relapse. Conclusion: Pregnancy after ER-positive BC does not seem to reduce the risk of BC recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Peccatori, F. A., Azim, H. A., Orecchia, R., Hoekstra, H. J., Pavlidis, N., Kesic, V., & Pentheroudakis, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt199 · Cited by 790
Self-citationCancer and fertility preservation: international recommendations from an expert meeting
Lambertini, M., Del Mastro, L., Pescio, M. C., Andersen, C. Y., Azim, H. A., Peccatori, F. A., Costa, M., Revelli, A., Salvagno, F., Gennari, A., et al. (2016) · BMC Medicine · doi:10.1186/s12916-015-0545-7 · Cited by 781
Self-citationRuddy, K. J., Gelber, S. I., Tamimi, R. M., Ginsburg, E. S., Schapira, L., Come, S. E., Borges, V. F., Meyer, M. E., & Partridge, A. H. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.8877 · Cited by 396
Self-citationLambertini, M., Moore, H. C. F., Leonard, R. C. F., Loibl, S., Munster, P., Bruzzone, M., Boni, L., Unger, J. M., Anderson, R. A., Mehta, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.0858 · Cited by 393
Progress in adjuvant systemic therapy for breast cancer
Pondé, N. F., Zardavas, D., & Piccart, M. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0089-9 · Cited by 281
Self-citationThe impact of cancer on subsequent chance of pregnancy: a population-based analysis
Anderson, R. A., Brewster, D. H., Wood, R., Nowell, S., Fischbacher, C., Kelsey, T. W., & Wallace, W. H. B. (2018) · Human Reproduction · doi:10.1093/humrep/dey216 · Cited by 254
Fertility preservation in breast cancer patients
Shien, T., Nakatsuka, M., & Doihara, H. (2014) · Breast Cancer · doi:10.1007/s12282-013-0463-5 · Cited by 7
Metadata
- Authors
- Azim, H. A., Kroman, N., Paesmans, M., Gelber, S., Rotmensz, N., Ameye, L., De Mattos-Arruda, L., Pistilli, B., Pinto, A., Jensen, M.-B., Cordoba, O., de Azambuja, E., Goldhirsch, A., Piccart, M. J., & Peccatori, F. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-01-01
- Volume
- 31
- Issue
- 1
- Pages
- 73-79
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2132412251
- Cited by
- 249
- References
- 0
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.